It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Reactive astrocytes evolve after brain injury, inflammatory and degenerative diseases, whereby they undergo transcriptomic re-programming. In malignant brain tumors, their function and crosstalk to other components of the environment is poorly understood. Here we report a distinct transcriptional phenotype of reactive astrocytes from glioblastoma linked to JAK/STAT pathway activation. Subsequently, we investigate the origin of astrocytic transformation by a microglia loss-of-function model in a human organotypic slice model with injected tumor cells. RNA-seq based gene expression analysis of astrocytes reveals a distinct astrocytic phenotype caused by the coexistence of microglia and astrocytes in the tumor environment, which leads to a large release of anti-inflammatory cytokines such as TGFβ, IL10 and G-CSF. Inhibition of the JAK/STAT pathway shifts the balance of pro- and anti-inflammatory cytokines towards a pro-inflammatory environment. The complex interaction of astrocytes and microglia cells promotes an immunosuppressive environment, suggesting that tumor-associated astrocytes contribute to anti-inflammatory responses.
Astrocytes play important roles in neuroinflammatory diseases. Here the authors characterize human glioblastoma-associated astrocytes by gene expression and demonstrate their immunosuppressive role promoted by interactions with tumor and microglia cells in an organotypic model.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 University of Freiburg, Translational NeuroOncology Research Group, Medical Center, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Department of Neurosurgery, Medical Center, Freiburg, Germany (GRID:grid.5963.9); Freiburg University, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9)
2 University of Freiburg, Neuroelectronic Systems, Medical Center, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Department of Neurosurgery, Medical Center, Freiburg, Germany (GRID:grid.5963.9); Freiburg University, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9)
3 University of Freiburg, Department of Neurosurgery, Medical Center, Freiburg, Germany (GRID:grid.5963.9); Freiburg University, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9)
4 University of Freiburg, Department of Neuroradiology, Medical Center, Freiburg, Germany (GRID:grid.5963.9); Epilepsy Center for Children and Adolescents, Clinic for Neuropediatrics and Neurorehabilitation, Schön Klinik, Germany (GRID:grid.5963.9)
5 University of Bonn, Department of Neurosurgery, Bonn, Germany (GRID:grid.10388.32) (ISNI:0000 0001 2240 3300)
6 University of Aachen, Department of Neurosurgery, Aachen, Germany (GRID:grid.1957.a) (ISNI:0000 0001 0728 696X)
7 University of Freiburg, Institute of Neuropathology, Medical Center, Freiburg, Germany (GRID:grid.5963.9); Freiburg University, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9)
8 University of Freiburg, Institute of Neuropathology, Medical Center, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Signalling Research Centres BIOSS and CIBSS, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Center for NeuroModulation (NeuroModul), Freiburg, Germany (GRID:grid.5963.9); Freiburg University, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9)